High prevalence of human papillomavirus infections in urine samples from human immunodeficiency virus-infected men

Journal of Clinical Microbiology

Volumn 43, Issue 12, 2005, Pages 5936-5939

  Smits, Paul H M ^a   Bakker, Remco ^a   Jong, Eefje ^a   Mulder, Jan Willem ^a   Meenhorst, Pieter L ^a   Kleter, Bernhard ^b   Van Doorn, Leen Jan ^b   Quint, Wim G V ^b  

^a SLOTERVAART HOSPITAL   (Netherlands)

^b Delft Diagnostic Laboratory   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DNA DETERMINATION; GENOTYPE; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PERSISTENT VIRUS INFECTION; PREVALENCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; URINALYSIS; VIRUS LOAD; WART VIRUS;

DNA, VIRAL; GENOTYPE; HIV INFECTIONS; HUMANS; MALE; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PREVALENCE; URINE; VIRAL LOAD;

DNA VIRUSES; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPES;

EID: 30744434414     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.43.12.5936-5939.2005     Document Type: Article

References (34)

1. Ahdjeh, L., R. S. Klein, R. Burk, S. Cu-Uvin, P. Schuman, A. Duerr, M. Safaeian, J. Astemborski, R. Daniel, and K. Shah. 2001. Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women. J. Infect. Dis. 184:682-690.
2. Baldwin, S. B., D. R. Wallace, M. R. Papenfuss, M. Abrahamsen, L. C. Vaught, J. R. Kornegay, J. A. Hallum, S. A. Redmond, and A. R. Giuliano. 2003. Human papillomavirus infection in men attending a sexually transmitted disease clinic. J. Infect. Dis. 187:1064-1070.
3. Bauer, H. M., Y. Ting, C. E. Greer, J. C. Chambers, C. J. Tashiro, J. Chimera, A. Reingold, and M. M. Manos. 1991. Genital human papillomavirus infection in female university students as determined by a PCR-hased method. JAMA 265:472-477.
4. Blank, B. S., P. L. Meenhorst, J. W. Mulder, G. J. Weverling, H. Putter, W. Pauw, W. C. van Dijk, P. Smits, A. L. Lie, P. Reiss, and J. M. Lange. 2000. Value of different assays for detection of human cytomegalovirus (HCMV) in predicting the development of HCMV disease in human immunodeficiency virus-infected patients. J. Clin. Microbiol. 38:563-569.
5. Boom, R., C. J. Sol, M. M. Salimans, C. L. Jansen, P. M. Wertheim-van Dillen, and N. J. van der. 1990. Rapid and simple method for purification of nucleic acids. J. Clin. Microbiol. 28:495-503.
6. Bosch, F. X., A. Lorincz, N. Munoz, C. J. Meijer, and K. V. Shah. 2002. The causal relation between human papillomavirus and cervical cancer. J. Clin. Pathol. 55:244-265.
7. Brinkman, J. A., W. E. Jones, A. M. Gaffga, J. A. Sanders, A. K. Chaturvedi, I. J. Slavinsky, J. L. Clayton, J. Dumestre, and M. E. Hagensee. 2002. Detection of human papillomavirus DNA in urine specimens from human immunodeficiency virus- positive women. J. Clin. Microbiol. 40:3155-3161.
8. Brown, D. R., J. T. Bryan, H. Cramer, B. P. Katz, V. Handy, and K. H. Fife. 1994. Detection of multiple human papillomavirus types in condylomata acuminata from immunosuppressed patients. J. Infect. Dis. 170:759-765.
9. Clarke, B., and R. Chetty. 2002. Postmodern cancer: the role of human immunodeficiency virus in uterine cervical cancer. Mol. Pathol. 55:19-24.
10. Crotchfelt, K. A., B. Pare, C. Gaydos, and T. C. Quinn. 1998. Detection of Chlamydia trachomatis by the Gen-Probe AMPLIFIED Chlamydia Trachomatis Assay (AMP CT) in urine specimens from men and women and endocervical specimens from women. J. Clin. Microbiol. 36:391-394.
11. Einstein, M. H., and A. S. Radish. 2004. Anogenital neoplasm in AIDS. Curr. Opin. Oncol. 16:455-462.
12. Gichangi, P. B., J. Bwayo, B. Estambale, H. De Vuyst, S. Ojwang, K. Rogo, H. Abwao, and M. Temmerman. 2003. Impact of HIV infection on invasive cervical cancer in Kenyan women. AIDS 17:1963-1968.
13. Hagensee, M. E., J. E. Cameron, J. E. Leigh, and R. A. Clark. 2004. Human papillomavirus infection and disease in HIV-infected individuals. Am. J. Med. Sci. 328:57-63.
14. Hawes, S. E., C. W. Critchlow, M. A. Faye Niang, M. B. Diouf, A. Diop, P. Toure, K. A. Aziz, B. Dembele, S. P. Salif, A. M. Coll-Seek, J. M. Kuypers, and N. B. Kiviat. 2003. Increased risk of high-grade cervical squamous intraepithelial lesions and invasive cervical cancer among African women with human immunodeficiency virus type 1 and 2 infections. J. Infect. Dis. 188:555-563.
15. Kleter, B., L. J. van Doorn, L. Schrauwen, A. Molijn, S. Sastrowijoto, J. ter Schegget, J. Lindeman, B. ter Harmsel, M. Burger, and W. Quint. 1999. Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J. Clin. Microbiol. 37:2508-2517.
16. Kleter, B., L. J. van Doorn, J. ter Schegget, L. Schrauwen, K. van Krimpen, M. Burger, B. ter Harmsel, and W. Quint. 1998. Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses. Am. J. Pathol. 153:1731-1739.
17. Levi, J. E., B. Kleter, W. G. Quint, M. C. Fink, C. L. Canto, R. Matsubara, I. Linhares, A. Segurado, B. Vanderborght, J. E. Neto, and L. J. van Doorn. 2002. High prevalence of human papillomavirus (HPV) infections and high frequency of multiple HPV genotypes in human immunodeficiency virus-infected women in Brazil. J. Clin. Microbiol. 40:3341-3345.
18. Longworth, M. S., and L. A. Laimins. 2004. Pathogenesis of human papillomaviruses in differentiating epithelia. Microbiol. Mol. Biol. Rev. 68:362-372.
19. Melchers, W. J., R. Schift, E. Stolz, J. Lindeman, and W. G. Quint. 1989. Human papillomavirus detection in urine samples from male patients by the polymerase chain reaction. J. Clin. Microbiol. 27:1711-1714.
20. Morrison, E. A., G. Y. Ho, S. H. Vermund, G. L. Goldberg, A. S. Radish, K. F. Kelley, and R. D. Burk. 1991. Human papillomavirus infection and other risk factors for cervical neoplasia: a case-control study. Int. J. Cancer 49:6-13.
21. Moscicki, A. B., J. H. Ellenberg, S. Farhat, and J. Xu. 2004. Persistence of human papillomavirus infection in HIV-infected and -uninfected adolescent girls: risk factors and differences, by phylogenetic type. J. Infect. Dis. 190: 37-45.
22. Munoz, N., F. X. Bosch, S. de Sanjose, R. Herrero, X. Castellsague, K. V. Shah, P. J. Snijders, and C. J. Meijer. 2003. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 348:518-527.
23. Nobbenhuis, M. A., J. M. Walboomers, T. J. Heimerhorst, L. Rozendaal, A. J. Remmink, E. K. Risse, H. C. van der Linden, F. J. Voorhorst, P. Kenemans, and C. J. Meijer. 1999. Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study. Lancet 354:20-25.
24. Ogunbiyi, O. A., J. H. Scholefield, A. T. Raftery, J. H. Smith, S. Duffy, F. Sharp, and K. Rogers. 1994. Prevalence of anal human papillomavirus infection and intraepithelial neoplasia in renal allograft recipients. Br. J. Surg. 81:365-367.
25. Palefsky, J. M. 2000. Anal squamous intraepithelial lesions in human immunodeficiency virus-positive men and women. Scmin. Oncol. 27:471-479.
26. Palefsky, J. M., E. A. Holly, M. L. Ralston, M. Da Costa, and R. M. Greenblatt. 2001. Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women. J. Infect. Dis. 183:383-391.
27. Piketty, C., T. M. Darragh, M. Da Costa, P. Bruneval, I. Heard, M. D. Kazatchkine, and J. M. Palefsky. 2003. High prevalence of anal human papillomavirus infection and anal cancer precursors among HIV-infected persons in the absence of anal intercourse. Ann. Intern. Med. 138:453-459.
28. Sun, X. W., L. Kuhn, T. V. Ellerbrock, M. A. Chiasson, T. J. Bush, and T. C. Wright, Jr. 1997. Human papillomavirus infection in women infected with the human immunodeficiency virus. N. Engl. J. Med. 337:1343-1349.
29. van der Graaf, Y., A. Molijn, H. Doornewaard, W. Quint, L. J. van Doorn, and T. J. van den Tweel. 2002. Human papillomavirus and the long-term risk of cervical neoplasia. Am. J. Epidemiol. 156:158-164.
30. van der Snoek, E. M., H. G. Niesters, P. G. Mulder, G. J. van Doornum, A. D. Osterhaus, and W. I. van der Meijden. 2003. Human papillomavirus infection in men who have sex with men participating in a Dutch gay-cohort study. Sex. Transm. Dis. 30:639-644.
31. Weissenborn, S. J., A. M. Funke, M. Hellmich, P. Mallmann, P. G. Fuchs, H. J. Pfister, and U. Wieland. 2003. Oncogenic human papillomavirus DNA loads in human immunodeficiency virus-positive women with high-grade cervical lesions are strongly elevated. J. Clin. Microbiol. 41:2763-2767.
32. Wilkin, T. J., S. Palmer, K. F. Brudney, M. A. Chiasson, and T. C. Wright. 2004. Anal intraepithelial neoplasia in heterosexual and homosexual HIV-positive men with access to antiretroviral therapy. J. Infect. Dis. 190:1685-1691.
33. zur Hausen, H. 1996. Papillomavirus infections-a major cause of human cancers. Biochim. Biophys. Acta 1288:F55-F78.
34. zur Hausen, H. 2002. Papillomaviruses and cancer: from basic studies to clinical application. Nat. Rev. Cancer 2:342-350.